EXI1:F:F-iShares SLI UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 142.52

Change

-0.24 (-0.17)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.27 (+1.02%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.43 (+0.87%)

USD 114.95B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 98.13B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 91.82B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.14 (+0.93%)

USD 54.47B
VUSA:F Vanguard Funds Public Limited ..

+0.66 (+0.66%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.06 (+0.06%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+2.55 (+1.09%)

USD 50.58B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 40.89B
0ZC:F Zscaler Inc

+4.26 (+2.56%)

USD 37.92B

ETFs Containing EXI1:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.08% 56% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.08% 56% F 62% D
Trailing 12 Months  
Capital Gain 19.97% 67% D+ 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.97% 67% D+ 66% D+
Trailing 5 Years  
Capital Gain 45.22% 73% C 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 45.22% 73% C 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 9.40% 70% C- 67% D+
Dividend Return 9.40% 68% D+ 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.25% 55% F 84% B
Risk Adjusted Return 76.77% 83% B 87% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike